Parameter
| Biomarker | anti-β2-GPⅠ antibodies | Full name | Anti-beta-2-Glycoprotein Ⅰ antibodies | Molecular Type | Protein (autoantibody) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis, thrombosis risk assessment |
| Disease | Autoimmune Disease (AD) | Disease Subtypes | / | ||
| Organ | Spleen, thymus, lymphoid tissue | Test Sample / Technology Platform | Serum (ELISA) | ||
| Pathobiological Mechanisms | The target antigen is β2-glycoprotein I, which participates in coagulation/anticoagulation regulation. | ||||
| Clinical Availability Status | Clinically available: higher specificity than aCL. | ||||
| Notes and Dynamics | It has significant supplementary diagnostic value for aCL-negative suspected APS patients. | ||||